Continued Quality Push Among China's 2016 Regulatory Trends To Watch
This article was originally published in The Tan Sheet
The China pharma market in 2015 was marked by a drastic market slowdown and turbulent regulatory headwinds. But looking ahead, analysts say while challenges remain, some important breakthroughs could be on the way.
You may also be interested in...
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization has arrived in the city to investigate its origin. Meanwhile, mixed results are reported for some of the leading Chinese vaccines being developed to fight the pandemic still wreaking global havoc.